39
Views
2
CrossRef citations to date
0
Altmetric
Editorial

Risks and benefits of allergen immunotherapy

&
Pages 253-256 | Published online: 12 May 2009

Bibliography

  • Pajno GB, Barberio G, De Luca F, et al. Prevention of new sensitization in asthmatic children monosentizes to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001;31:1392-7
  • Eng PA, Reinhold M, Genhm HP. Long term efficacy preaesonal grass pollen immunotherapy in children. Allergy 2002;57:306-12
  • Moller C, Dreborg Ferdousi HA, Halken S, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctativitis: the PAT study. J Allergy Clin Immunol 2002;109:251-6
  • Eng PA, Boret-Reinhold M, Heijnen IA, Gnehm HP. Tweleve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood. Allergy 2006;61(2):198-201
  • Moreno C, Cuesta-Herranz J, Farnade-Tavora L, Alvarez-Cuesta E. Immunotherapy safety: prospecitive multi-center, monitoring study of biologically standardized therapeutic vaccines for allergic diseases. Clin Exp Allergy 2004;34:527-31
  • Kelso JM. The rate of systemic reactions to immunotherapy injections is the same whether or not the dose is reduced after a local reactions. Ann Allergy Asthma Immunol 2004;92:235-7
  • Roy SR, Sigmon JR, Olivier J, et al. Increased frequency of large local reactions among systematic reactors during subcutaneous allergen immunotherapy. Ann Allergy Asthma Immunol 2007;99(1):82-6
  • Coop CA, Tankersiey MS. Dose adjustment practices among allergists for local reactions to immunotherapy. Ann Allergy Asthma Immunol 2007;99(1):77-81
  • Mauro M, Russello M, Incorvaia C, et al. Comparison of efficacy, safety and immunologic effects of subcutaneus and sublingual immunotherapy in birch pollinosis: a randomized study. Eur Ann Alerg Clin Immunol 2007;39(4):119-22
  • Cox L, Nelson H, Lockey R. Allergen immunotherapy: a practice parameter second update. J Allergy Clin Immunol 2007;120(suppl 3)
  • Rank MA, Osilie CL, Krogman JL, et al. Alergen immunotherapy safety: characterizing systemie reactions and identifying risk factors. Allergy Asthma Proc 2008;29(4):400-5
  • Norman PS. Immunotherapy: 1999-2004. J Allergy Clin Immunol 2004;113(6):1013-23
  • Bousquet J, Hejjaoui A, Dhivert H, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. Systemic reactions during the rush protocol in patients suffering from asthma. J Allergy Clin Immunol 1989;83;792-802
  • Bernstein DI, Wanner M, Borish L, Liss GM. Immunotherapy Committee, American Academy of allergy, asthma and Immunology. J Allergy Clin Immunol 2004;113(6):1129-36
  • Luderitz-Puchel U, Keller-Stanisawski B, HAustein D. Neubewertung des Risikos von Test-und Therapieallergenen. Gesundheitsforsch Gesundheitsschutz 2001;44:709-18
  • Amin HS, Liss GM, Bernstein Dl. Evaluation of near-fatal reactions to allergen immunotherapy injections. J Allergy Clin Immunol 2006;117:169-75
  • Ameal A, Vega-Chicote JM, Fernandez S. Double-blind and placebo controlled study to assessefficacy and safety of a modified allergen extract of Dermatophagoides pteronyssimus on allergic asthma. Allergy 2005;60:1179-83
  • Muller U, Hari Y, Berchtold E. Premedication with antihistamines may enhance efficacy of specific allergen immunotherapy. J Allergy Clin Immunol 2001;107:81-6
  • Ohashi Y, Nkai Y, Murata K. Effect of pretreatment with fexofenadine on the safety of immunotherapy in patients with allergic rhinitis. Ann Allergy Asthma Immunol 2006;96:600-5
  • Jutel M, Watanabe T, Klunker S, et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 2001;413(6854):420-5
  • Casale TB, Busse WW, Kline JN, et al. Immune Tolerance Network Group: omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis. J Allergy Clin Immunol 2006;117:134-40
  • Rogala B, Glück J. Allergen-specific IgE in circulating immune complexes in patients with inhalant allergy undergoing specific immunotherapy. Invest Allergol Clin Immunol 1991;9(3):183-9
  • Stock P, Rolinck-Werninghaus C, Wahan U, Hamelmann E. The role of anti-IgE therapy in combination with allergen specific immunotherapy for seasonal allergic rhinitis. Bio Drugs 2007;21(6):403-10
  • Magnan A, Humbert M. Is deficient tolerance the true paradigm for atopic diseases? Clin Exp Allergy 2005;35:1507-10
  • Pfaar O, Klimek L. Efficacy and safety of specific immunotherapy with a high-dose sublingual grass pollen preparation: a double-blind, placebo-controleed trial. Ann Allergy Asthma Immunol 2008;100(3):256-63
  • Passalacqua G, Guerra L, Compalati E, Canonica GW. The safety of allergen specific sublingual immunotherapy. Curr Drug Saf 2007;2(2):117-23
  • Cox L. Sublingual immunotherapy in pediatric allergic rhinitis and asthma: efficacy safety, and practical considerations. Curr Allergy Asthma Rep 2007;7(6):410-20
  • Ibañez MD, Kaiser F, Knecht R, et al. Safety of specific sublingual immunotherapy with SQ standardized grass allergen tablets in children. Pediatr Allergy Immunol 2007;18(6):516-22
  • Blazowski L. Anaphylactic shock because of sublingual immunotherapy overdose during third year of maintenance dose. Allergy 2008;63:374-81

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.